Kirin and Fujitsu elucidate a novel gut-brain axis mechanism of citicoline for the first time worldwide through AI-based analysis and experimental validation leveraging drug discovery DX technology

Tokyo and Kawasaki, Japan, Dec 19, 2025 – (JCN Newswire) – Kirin Holdings Company, Limited and Fujitsu Limited have jointly conducted research on food functionality simulation with the goal of creating new functionalities in food. This research utilized QSP (Quantitative Systems Pharmacology) models[1], one of the AI-driven digital transformation (DX) technologies for drug discovery[2…
Read More